Hello, Guest
Login
Sign Up
 
 

Top Stocks Trading Alert: HNR, SPWR, YGE, PFE

HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.

 
 
Repost This

Los Angelas, CA -- (SBWIRE) -- 02/11/2013 -- Harvest Natural Resources, Inc. (NYSE:HNR) soared 4.86% to $9.50 in the pre-market trading hours. The Company updated on its drilling operations in the Dussafu Tortue Marin-1 well drilled in the Dussafu Marin PSC, offshore Gabon, West Africa. The DTM-1 well was initially drilled in 380 feet of water to a vertical depth of 11,260 feet. Harvest announced an oil discovery in the pre-salt Gamba and Dentale reservoirs with plans to drill a sidetrack to appraise the extent of the Dentale oil discovery.

What Should Investors Do With HNR Now? Find Out Here

SunPower Corporation (NASDAQ:SPWR) opened at $7.84 with 161.08 million outstanding shares and touch its highest price of $8.12 of the day and then finished at $7.93 by scoring -5.60%, as in the whole session stocks gain volume of 4.33 million shares which is higher than its average volume.

Is SPWR Showing Any Sign of Buy At The Current Market Price? Find Out Here

Yingli Green Energy Holding Co. Ltd. (NYSE:YGE) is trading a t $3.2455, up 0.1555 or 5.03%m, with a morning high of $3.30 on just under one million shares, the company, on Feb. 4, announced that the Company has supplied 65 kilowatts of PV modules for Kawkabuna for Energy Solutions (“Kawkabuna”), which is a specialized company in Jordan providing energy saving solutions. This is Yingli Green Energy’s first order in the Jordanian market.

How Should Investors Trade YGE After Today’s Rally? Find Out Here

Pfizer Inc. (NYSE:PFE) topped the volume gainers chart with robust volume of 37.45 million, but the stock ended the day with a negative change of -0.30%. Pfizer needs to cut over $1 billion from its budget and has assured plans to get out of a clinical research process in Singapore, suggesting that even research in the swiftly-developing Asia-Pacific zone is not safe from cut backs.

Is PFE Showing Any Sign of Buy At The Current Market Price? Find Out Here

DISCLAIMER
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com